Abstract
Mycosis fungoides (MF) is the most common primary cutaneous T-cell lymphoma. This cancer characteristically
affects the skin, causing different types of skin lesions that progress slowly through several
stages, although not all people with the condition progress through all stages.We present a case of MF in
a 32-year-old female patient with many years of nonspecific eczematous and psoriasiform skin lesions
and non-diagnostic biopsies. The diagnosis of MF can be very difficult and misleading. The wide range of
clinical and pathological presentations of MF makes this disease a challenge for diagnosis and, therefore,
requires an accurate differential diagnosis integrated by the patient's clinic together with the histological
and immunological findings.
Keywords:
T-cell lymphoma, clinical manifestations, histology, immunological labeling
References
1Mu~noz-Gonzalez H, Molina-Ruiz AM, Requena L. Clinicopathologic variants of mycosis fungoides. Actas Dermosifiliogr. 2017;108(3):192e208. https://doi.org/ 10.1016/j.adengl.2017.02.010.
2Beyer M, M€obs M, Humme D, Sterry W. Pathogenesis of mycosis fungoides. J Dtsch Dermatol Gest. 2011;9(8):594e598. https://doi.org/10.1111/j.1610- 0387.2011.07635.x.
3Korgavkar K, Xiong M, Weinstock M. Changing incidence trends of cutaneous T-cell lymphoma. JAMA Dermatol. 2013;149(11):1295. https://doi.org/10.1001/ jamadermatol.2013.5526.
4Larocca C, Kupper T. Mycosis fungoides and Sezary syndrome. Hematol Oncol Clin N Am. 2019;33(1):103e120. https://doi.org/10.1016/j.hoc.2018.09.001.
5Cervini AB, Torres-Huamani AN, Sanchez-La-Rosa C, et al. Mycosis fungoides: experience in a pediatric hospital. Actas Dermosifiliogr. 2017;108(6):564e570. https://doi.org/10.1016/j.adengl.2017.05.013.
6Girardi M, Heald PW, Wilson LD. The pathogenesis of mycosis fungoides. N Engl J Med. 2004;350(19):1978e1988. https://doi.org/10.1056/NEJMra032810.
7Wilcox RA. Cutaneous T-cell lymphoma: 2016 update on diagnosis, riskstratification, and management. Am J Hematol. 2016;91(1):151e165. https:// doi.org/10.1002/ajh.24233.
8Kazakov D, Burg G, Kempf W. Clinicopathological spectrum of mycosis fungoides. J Eur Acad Dermatol Venereol. 2004;18(4):397e415. https://doi.org/ 10.1111/j.1468-3083.2004.00937.x.
9Ahn CS, ALSayyah A, Sangüeza OP. Mycosis fungoides. Am J Dermatopathol. 2014;36(12):933e951. https://doi.org/10.1097/DAD.0000000000000207.
10Virmani P, Myskowski PL, Pulitzer M. Unusual variants of mycosis fungoides. Diagn Histopathol. 2016;22(4):142e151. https://doi.org/10.1016/ j.mpdhp.2016.04.004.
11Jaque A, Mereniuk A, Walsh S, et al. Influence of the phenotype on mycosis fungoides prognosis, a retrospective cohort study of 160 patients. Int J Dermatol. February 2019:1e7. https://doi.org/10.1111/ijd.14391.
12Berg S, Villasenor-Park J, Haun P, Kim EJ. Multidisciplinary management of mycosis fungoides/Sezary syndrome. Curr Hematol Malig Rep. 2017;12(3): 234e243. https://doi.org/10.1007/s11899-017-0387-9.
